AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

WARFARIN SODIUM

9 registrations across 4 African markets— 6 active

Markets with WARFARIN SODIUM

🇿🇦South Africa
5 registrations
2 active
🇿🇼Zimbabwe
2 registrations
2 active
🇳🇬Nigeria
1 registration
1 active
🇿🇲Zambia
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
Decot Tablets (Warfarin Sodium USP 5mg)
Tablets+ Filmcoated
🇿🇲ZambiaMacleods Pharmaceuticals LimitedactiveJul 2030
Multichris Warfarin Tablets
Tablet
🇳🇬NigeriaMultichris Pharmaceutical and Chemical Company LimitedactiveJan 2029
WARFARIN 5 BIOTECH🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveSept 2028
HEAMAWARIN🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveSept 2028
DECLOT 0.5
TABLET, COATED; ORAL
🇿🇼ZimbabweMACLEODS PHARMACEUTICALS LIMITEDactiveDec 2027
ASPEN- WARFARIN
TABLET; ORAL
🇿🇼ZimbabwePHARMACARE LTDactiveDec 2027
ZYWAR 1🇿🇦South AfricaZydus Healthcare (Pty) LtdsuspendedAug 2022
ZYWAR 2,5🇿🇦South AfricaZydus Healthcare (Pty) LtdsuspendedAug 2022
ZYWAR 5🇿🇦South AfricaZydus Healthcare (Pty) LtdsuspendedAug 2022

WARFARIN SODIUM in Africa — Regulatory Overview

WARFARIN SODIUM is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zimbabwe, Nigeria, Zambia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.